Market Research Logo

Hemispherx Biopharma Inc (HEB) - Financial and Strategic SWOT Analysis Review

Hemispherx Biopharma Inc (HEB) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), kidney cancer and metastatic malignant melanoma; multiple sclerosis, hepatitis C, HIV, west Nile virus, and SARS; and Alferon LDO (Low Dose Oral), an oral form of Alferon N Injection for influenza viruses. The company operates production facility in New Brunswick, New Jersey. Hemispherx is headquartered in Orlando, Florida, the US.

Hemispherx Biopharma Inc Key Recent Developments

May 16,2018: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update
May 14,2018: Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum
May 10,2018: Hemispherx to Present at the 8th Annual LD Micro Invitational
Apr 20,2018: Hemispherx Announces Pricing of 2.57 Million Registered Direct Offering at a Premium to Market
Apr 02,2018: Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Hemispherx Biopharma Inc - Key Facts
Hemispherx Biopharma Inc - Key Employees
Hemispherx Biopharma Inc - Key Employee Biographies
Hemispherx Biopharma Inc - Major Products and Services
Hemispherx Biopharma Inc - History
Hemispherx Biopharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Hemispherx Biopharma Inc - Business Description
Hemispherx Biopharma Inc - SWOT Analysis
SWOT Analysis - Overview
Hemispherx Biopharma Inc - Strengths
Hemispherx Biopharma Inc - Weaknesses
Hemispherx Biopharma Inc - Opportunities
Hemispherx Biopharma Inc - Threats
Hemispherx Biopharma Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Hemispherx Biopharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 16, 2018: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update
May 14, 2018: Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum
May 10, 2018: Hemispherx to Present at the 8th Annual LD Micro Invitational
Apr 20, 2018: Hemispherx Announces Pricing of 2.57 Million Registered Direct Offering at a Premium to Market
Apr 02, 2018: Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017
Jan 29, 2018: Hemispherx to Present at the BIO CEO & Investor Conference
Dec 29, 2017: Hemispherx Biopharma to Present at Biotech Showcase 2018
Dec 19, 2017: Hemispherx Highlights Year-To-Date Progress, Outlines Key Objectives
Nov 15, 2017: Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017
Aug 15, 2017: Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Six Months Ended June 30, 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Hemispherx Biopharma Inc, Key Facts
Hemispherx Biopharma Inc, Key Employees
Hemispherx Biopharma Inc, Key Employee Biographies
Hemispherx Biopharma Inc, Major Products and Services
Hemispherx Biopharma Inc, History
Hemispherx Biopharma Inc, Other Locations
Hemispherx Biopharma Inc, Subsidiaries
Hemispherx Biopharma Inc, Key Competitors
Hemispherx Biopharma Inc, Ratios based on current share price
Hemispherx Biopharma Inc, Annual Ratios
Hemispherx Biopharma Inc, Annual Ratios (Cont...1)
Hemispherx Biopharma Inc, Interim Ratios
Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Hemispherx Biopharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Hemispherx Biopharma Inc, Performance Chart (2013 - 2017)
Hemispherx Biopharma Inc, Ratio Charts
Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report